The invention relates to the combined administration of PDE inhibitors and .beta..sub.2 adrenoceptor agonists for the treatment of respiratory tract disorders.

 
Web www.patentalert.com

< Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer

< Rotamase enzyme activity inhibitors

> Sulfonylquinoxalone derivatives as bradykinin antagonists

> 4-(4Methoxybenzyl)-n'-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)
~ 00267